ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Algernon Pharmaceuticals Inc (QB)

Algernon Pharmaceuticals Inc (QB) (AGNPF)

0,052
0,00
( 0,00% )
Aktualisiert: 16:55:45

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,052
Gebot
0,048
Fragen
0,063
Volumen
3.500
0,046 Tagesbereich 0,056
0,0441 52-Wochen-Bereich 0,123
Marktkapitalisierung
Handelsende
0,052
Handelsbeginn
0,046
Letzte Trade
1000
@
0.052
Letzter Handelszeitpunkt
16:40:37
Finanzvolumen
US$ 189
VWAP
0,054
Durchschnittliches Volumen (3 Mio.)
4.885
Ausgegebene Aktien
21.940.779
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,16
Gewinn pro Aktie (EPS)
-0,31
Erlöse
-
Nettogewinn
-6,78M

Über Algernon Pharmaceuticals Inc (QB)

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically inv... Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
Algernon Pharmaceuticals Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker AGNPF. The last closing price for Algernon Pharmaceuticals (QB) was US$0,05. Over the last year, Algernon Pharmaceuticals (QB) shares have traded in a share price range of US$ 0,0441 to US$ 0,123.

Algernon Pharmaceuticals (QB) currently has 21.940.779 shares in issue. The market capitalisation of Algernon Pharmaceuticals (QB) is US$1,14 million. Algernon Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of -0.16.

AGNPF Neueste Nachrichten

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

VANCOUVER, British Columbia, Feb. 10, 2021 -- InvestorsHub NewsWire -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or...

Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

Algernon Receives U.S. FDA Clearance for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19 VANCOUVER, British Columbia, June 04, 2020...

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board VANCOUVER, British Columbia, Canada...

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use VANCOUVER, British Columbia, Canada -- March 13, 2020...

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus VANCOUVER, British Columbia, Canada -- March 6, 2020 -- InvestorsHub NewsWire -- Algernon...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.00050.9708737864080.05150.05980.04529460.05304557CS
4-0.0043-7.637655417410.05630.070.04548460.05866084CS
12-0.03312-38.90977443610.085120.085120.04548850.06426229CS
26-0.063-54.78260869570.1150.1230.04572960.08222802CS
520.00387.883817427390.04820.1230.0441124830.07362387CS
1560.04325494.2857142860.008752.3198750.0085119890.19622197CS
2600.0424200.012.3198750.00852742200.05765536CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AGDXFAntioqua Gold Inc (CE)
US$ 0,02
(1.999.900,00%)
2,5k
CNONFLynx Global Digital Finance Corporation (CE)
US$ 0,001
(99.900,00%)
174
ISUNQiSun Inc (CE)
US$ 0,0007
(69.900,00%)
19,26k
MGTIMGT Capital Investments Inc (CE)
US$ 0,0002
(19.900,00%)
125,2k
TTCFQTattooed Chef Inc (CE)
US$ 0,0002
(19.900,00%)
54,99k
EGBBEarth Gen Biofuel Inc (CE)
US$ 0,000001
(-99,95%)
8k
CNVIFConavi Medical Corporation (PK)
US$ 0,0007
(-99,88%)
1,97k
BDPTDBioadaptives Inc
 0,0251
(-99,72%)
92,33k
SPRNSupernova Energy Inc (CE)
US$ 0,000001
(-99,67%)
2k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0,000001
(-99,50%)
2,4k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
230,2M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,000001
(0,00%)
140,37M
HMBLHUMBL Inc (PK)
US$ 0,0003
(0,00%)
124,15M
THBDThird Bench Inc (PK)
US$ 0,0002
(100,00%)
112,63M
RDARRaadr Inc (PK)
US$ 0,0007
(16,67%)
100,16M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock